HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Johann de Bono Selected Research
Johann de Bono Research Topics
Disease
83
Prostatic Neoplasms (Prostate Cancer)
06/2022 - 06/2008
66
Neoplasms (Cancer)
01/2022 - 01/2003
13
Neoplasm Metastasis (Metastasis)
01/2022 - 06/2009
10
Pain (Aches)
06/2022 - 11/2013
8
Disease Progression
01/2022 - 02/2014
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
5
Diarrhea
10/2021 - 08/2007
5
Nausea
01/2020 - 08/2007
4
Fatigue
01/2019 - 01/2015
3
Breast Neoplasms (Breast Cancer)
06/2022 - 02/2007
3
Asthenia
10/2021 - 02/2012
3
Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 01/2003
3
Exanthema (Rash)
11/2018 - 08/2007
2
Neutropenia
01/2022 - 03/2016
2
Carcinogenesis
01/2022 - 01/2018
2
Pleural Effusion (Pleural Effusions)
01/2022 - 01/2016
2
Infections
01/2021 - 12/2005
2
Bone Diseases (Bone Disease)
01/2017 - 10/2016
2
Carcinoma (Carcinomatosis)
04/2014 - 10/2008
2
Vomiting
02/2012 - 08/2007
1
Cancer Pain
01/2022
1
Febrile Neutropenia
01/2022
Drug/Important Bio-Agent (IBA)
20
Docetaxel (Taxotere)
FDA Link
01/2022 - 01/2013
18
enzalutamide
IBA
05/2022 - 09/2014
14
abiraterone
IBA
05/2022 - 01/2013
14
Pharmaceutical Preparations
IBA
01/2022 - 08/2007
12
Androgens
IBA
01/2022 - 08/2011
10
olaparib
IBA
05/2022 - 01/2018
10
Androgen Receptors (Androgen Receptor)
IBA
01/2022 - 01/2013
10
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 05/2006
9
Prostate-Specific Antigen (Semenogelase)
IBA
01/2022 - 11/2013
9
cabazitaxel
FDA Link
10/2021 - 03/2016
8
Hormones (Hormone)
IBA
01/2022 - 06/2008
7
taxane
IBA
06/2022 - 08/2015
7
Poly(ADP-ribose) Polymerase Inhibitors
IBA
10/2020 - 10/2016
7
Biomarkers (Surrogate Marker)
IBA
12/2018 - 08/2011
6
Proteins (Proteins, Gene)
FDA Link
01/2022 - 04/2015
6
Abiraterone Acetate
IBA
01/2019 - 01/2013
4
Prednisone (Sone)
FDA Link
Generic
01/2022 - 02/2014
4
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2018
3
Antigens
IBA
01/2022 - 01/2021
3
Ligands
IBA
12/2021 - 10/2007
3
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 02/2007
3
Biological Products
IBA
03/2021 - 01/2003
3
Afatinib
IBA
11/2018 - 12/2013
3
Lapatinib (GW572016)
FDA Link
02/2013 - 02/2007
2
Complement System Proteins (Complement)
IBA
06/2022 - 01/2018
2
talazoparib
IBA
06/2022 - 01/2017
2
Metformin (Glucophage)
FDA Link
Generic
01/2022 - 01/2022
2
Phosphoproteins
IBA
01/2022 - 01/2016
2
pembrolizumab
IBA
01/2022 - 01/2020
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022 - 01/2022
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2022 - 01/2018
2
Immunoconjugates (Immunoconjugate)
IBA
12/2021 - 01/2003
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2021 - 01/2017
2
Neutralizing Antibodies
IBA
01/2021 - 01/2008
2
rucaparib
IBA
10/2020 - 01/2018
2
Cell-Free Nucleic Acids
IBA
01/2020 - 01/2018
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2020 - 10/2016
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2018 - 01/2009
2
Paclitaxel (Taxol)
FDA Link
Generic
11/2018 - 01/2017
2
Transcription Factors (Transcription Factor)
IBA
01/2018 - 06/2008
2
Steroids
IBA
12/2017 - 01/2013
2
NVP-BKM120
IBA
01/2017 - 01/2017
2
Tensins
IBA
01/2017 - 04/2015
2
dactolisib
IBA
01/2017 - 01/2017
2
Luciferases
IBA
01/2017 - 04/2014
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2017 - 04/2015
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
04/2015 - 06/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
03/2015 - 01/2008
2
cantuzumab mertansine
IBA
10/2008 - 01/2003
1
Androgen Antagonists (Antiandrogens)
IBA
01/2022
1
Interferons
IBA
01/2022
1
NSC 724998
IBA
01/2022
1
COVID-19 Vaccines
IBA
01/2022
1
OTX015
IBA
01/2022
1
Opiate Alkaloids
IBA
01/2022
1
Lutetium-177
IBA
01/2022
1
Androgen Receptor Antagonists
IBA
01/2022
1
Double-Stranded RNA (RNA, Double Stranded)
IBA
01/2022
1
isatuximab
IBA
01/2022
1
cemiplimab
IBA
01/2022
1
Retroelements (Retrotransposon)
IBA
01/2022
1
Antibodies
IBA
01/2022
1
guadecitabine
IBA
01/2022
1
apalutamide
IBA
01/2022
1
darolutamide
IBA
01/2022
1
Tablets
IBA
01/2022
1
B7-H1 Antigen
IBA
01/2022
1
patritumab deruxtecan
IBA
12/2021
1
RNA (Ribonucleic Acid)
IBA
12/2021
1
Nivolumab
IBA
10/2021
Therapy/Procedure
60
Castration
06/2022 - 08/2011
40
Therapeutics
01/2022 - 12/2005
16
Drug Therapy (Chemotherapy)
06/2022 - 01/2003
2
Radiotherapy
01/2022 - 01/2018
2
Immunotherapy
01/2020 - 08/2011
1
Immunomodulation
01/2022
1
Fecal Microbiota Transplantation
10/2021
1
Precision Medicine
10/2021